NuvoBio Selected for the Second Merck Digital Science Studio (MDSS) Cohort
NuvoBio, a CBV SUMMIT level company, has been selected for the prestigious MDSS accelerator program. A one of only 12 startups chosen across North America, NuvoBio is redefining peptide discovery…